TESARIL D 100/10 Tablets – An innovative solution for enhanced glycemic control.
Tesaril D 100/10 – Dapagliflozin 10 mg + Sitagliptin 100 mg tablets features Sitagliptin, a DPP-4 inhibitor that increases incretin levels, enhancing insulin secretion and suppressing glucagon. Dapagliflozin, an SGLT2 inhibitor, works by preventing glucose reabsorption in the kidneys, promoting its excretion in urine and thereby lowering blood glucose levels. Together, they provide a comprehensive approach to managing type-2 diabetes, addressing multiple facets of glycemic control.
Recommended by specialists:
✅ Diabetologist: For diagnosing and treating diabetes mellitus.
✅ General Physician: For management of type 2 diabetes and glycemic control
Key benefits of Dapagliflozin 10 mg + Sitagliptin 100 mg tablets – TESARIL D 100/10 Tablets
✅ Combination of DPP-4 Inhibition and SGLT2 Inhibition: Sitagliptin enhances incretin levels to stimulate insulin release and decrease glucagon secretion, while Dapagliflozin promotes glucose excretion through urine, providing synergistic effects on blood sugar control.
✅ Cardiovascular and Renal Benefits: Dapagliflozin has been shown to reduce cardiovascular risk and provide renal protection, making this combination particularly beneficial for patients with cardiovascular concerns or renal impairment.
✅ Convenient Dosing: A single tablet simplifies the treatment regimen, improving patient adherence and management of type 2 diabetes.
Indications
✅ Type 2 Diabetes Mellitus
✅ Inadequate glycemic control with monotherapy